Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 6, Pages 1377
Publisher
MDPI AG
Online
2021-06-02
DOI
10.3390/cells10061377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- “The use of bisphosphonates to treat skeletal complications in solid tumours”
- (2021) S. D’Oronzo- et al. BONE
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Limonoid Triterpene, Obacunone Increases Runt-Related Transcription Factor 2 to Promote Osteoblast Differentiation and Function
- (2021) Kyung-Ran Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC
- (2021) Malvika Sharma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1
- (2021) Mengmeng Liang et al. Molecular Therapy-Nucleic Acids
- Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
- (2021) Juliane Lehmann et al. iScience
- Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
- (2021) Elham Sajjadi et al. Cancer Cell International
- Rethinking the clinical management of volumetric muscle loss in patients with spinal cord injury: Synergy among nutritional supplementation, pharmacotherapy, and rehabilitation
- (2021) Marco Invernizzi et al. CURRENT OPINION IN PHARMACOLOGY
- A novel mouse model for SNP in Steroid Receptor Co-activator-1 reveals role in bone density and breast cancer metastasis
- (2021) Rebecca J Watters et al. ENDOCRINOLOGY
- Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2 ‐negative metastatic breast cancer
- (2021) Hyehyun Jeong et al. INTERNATIONAL JOURNAL OF CANCER
- Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases
- (2021) Peter Burckhardt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The human WNT5A isoforms display similar patterns of expression but distinct and overlapping activities in normal human osteoblasts
- (2021) Dristi Bhandari et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer
- (2021) Xiaoqing Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted therapy to β3 integrin reduces chemoresistance in breast cancer bone metastases
- (2021) Gregory C. Fox et al. MOLECULAR CANCER THERAPEUTICS
- SLPI is a critical mediator that controls PTH-induced bone formation
- (2021) Akito Morimoto et al. Nature Communications
- PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
- (2021) Nicola Fusco et al. Frontiers in Oncology
- Understanding the biology of volumetric muscle loss for an individualized exercise rehabilitation approach in breast cancer patients
- (2021) Marco Invernizzi et al. CURRENT OPINION IN PHARMACOLOGY
- Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany
- (2020) Ingo Diel et al. SUPPORTIVE CARE IN CANCER
- RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
- (2020) Xiaoqiu Wu et al. Frontiers in Cell and Developmental Biology
- Efficacy evaluation and mechanism study on inhibition of breast cancer cell growth by multimodal targeted nanobubbles carrying AMD070 and ICG
- (2020) Daijia Shen et al. NANOTECHNOLOGY
- Spinal Cord Injury as a Model of Bone-Muscle Interactions: Therapeutic Implications From in vitro and in vivo Studies
- (2020) Marco Invernizzi et al. Frontiers in Endocrinology
- Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study
- (2020) Soojung Hong et al. PLoS One
- Breast Cancer Survivorship, Quality of Life, and Late Toxicities
- (2020) Simone Nardin et al. Frontiers in Oncology
- Cathepsin K: The Action in and Beyond Bone
- (2020) Rongchen Dai et al. Frontiers in Cell and Developmental Biology
- Osteoclast Signal Transduction During Bone Metastasis Formation
- (2020) Dávid S. Győri et al. Frontiers in Cell and Developmental Biology
- Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions
- (2020) Jessica Jann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms of RANKL delivery to the osteoclast precursor cell surface
- (2020) Masashi Honma et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Osteoclast differentiation by RANKL and OPG signaling pathways
- (2020) Nobuyuki Udagawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mouse 4T1 Breast Cancer Cell–Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183
- (2020) Jian Guo et al. JOURNAL OF IMMUNOLOGY
- Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
- (2020) Lea Monteran et al. Scientific Reports
- CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation
- (2020) Jun Zhou et al. Molecular Therapy-Oncolytics
- Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
- (2020) Fabio Marazzi et al. Cancers
- The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer
- (2020) Augustus M. C. Tilley et al. Cancers
- The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
- (2020) Karolina A. Zielińska et al. Cancers
- The lingering mysteries of metastatic recurrence in breast cancer
- (2020) Alessandra I. Riggio et al. BRITISH JOURNAL OF CANCER
- Suppressive effects of an apoptotic mimicry prepared from jumbo-flying squid-skin phospholipids on the osteoclastogenesis in receptor activator of nuclear factor kappa B ligand/macrophage colony-stimulating factor-induced RAW 264.7 cells
- (2020) Yi-Feng Kao et al. Journal of the Chinese Medical Association
- Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (Review)
- (2020) Xiumao Li et al. Molecular Medicine Reports
- Editorial: Quality of Life in Breast Cancer Patients and Survivors
- (2020) Marco Invernizzi et al. Frontiers in Oncology
- Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors
- (2019) Gianluca Lopez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Bisphosphonates in Breast Cancer Therapy
- (2019) Hadar Goldvaser et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Bad to the Bone: The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis
- (2019) Guillaume Rieunier et al. CLINICAL CANCER RESEARCH
- IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis
- (2019) Mengmeng Liang et al. Cell Death & Disease
- Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy
- (2019) Aradhana Rani et al. Frontiers in Endocrinology
- TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
- (2019) Yang Hao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment
- (2019) Jinho Kang et al. Scientific Reports
- Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells
- (2019) Aude I. Segaliny et al. EBioMedicine
- Metastasis as a systemic disease: molecular insights and clinical implications
- (2019) Maša Alečković et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study
- (2019) Yeon-Hee Baek et al. Cancer Epidemiology
- A CTGF‐RUNX2‐RANKL Axis in Breast and Prostate Cancer cells Promotes Tumor Progression in Bone
- (2019) Bongjun Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- (2019) Yiran Liang et al. SEMINARS IN CANCER BIOLOGY
- The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer
- (2019) Ru Wang et al. BMC CANCER
- Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
- (2019) Fabio Pagni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging
- (2019) Yanli Peng et al. International Journal of Nanomedicine
- Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
- (2019) Michael R McClung et al. Lancet Diabetes & Endocrinology
- Structure–Function Relationship and Physiological Roles of Transient Receptor Potential Canonical (TRPC) 4 and 5 Channels
- (2019) Jinsung Kim et al. Cells
- Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression
- (2018) Yang Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Breast cancer bone metastases: pathogenesis and therapeutic targets
- (2018) Naomi Brook et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Parathyroid Hormone-Related Peptide Elicits Peripheral TRPV1-dependent Mechanical Hypersensitivity
- (2018) Andrew J. Shepherd et al. Frontiers in Cellular Neuroscience
- Bone metastasis pattern in initial metastatic breast cancer: a population-based study
- (2018) Zhenchong Xiong et al. Cancer Management and Research
- Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
- (2018) Alison B. Shupp et al. Cancers
- Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
- (2018) Brendan F. Boyce et al. Frontiers in Immunology
- The biology of normal bone remodelling
- (2017) P. Katsimbri EUROPEAN JOURNAL OF CANCER CARE
- Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia
- (2017) Nicola Fusco et al. HISTOPATHOLOGY
- Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases
- (2017) Andrew L. Himelstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer
- (2017) Gamal A. Elfar et al. ONCOLOGY RESEARCH
- The production of fibroblast growth factor 23 is controlled by TGF-β2
- (2017) Martina Feger et al. Scientific Reports
- Integrin αvβ3 Signaling in Tumor-Induced Bone Disease
- (2017) Kristin Kwakwa et al. Cancers
- Upregulation of the S1P 3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE 2 and EP 2 /EP 4 activation
- (2016) Iuliia Filipenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
- (2016) Anne F. Schott et al. BREAST CANCER RESEARCH AND TREATMENT
- TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
- (2016) Z. Mitri et al. CLINICAL CANCER RESEARCH
- Role of the RANK/RANKL pathway in breast cancer
- (2016) Ludwig Kiesel et al. MATURITAS
- Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression
- (2016) Sangmin Kim et al. TUMOR BIOLOGY
- IL-1 drives breast cancer growth and bone metastasis in vivo
- (2016) Ingunn Holen et al. Oncotarget
- Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
- (2016) Tamara Aleksic et al. Frontiers in Oncology
- Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms
- (2014) Jong-Ho Lee et al. BIOCHEMICAL PHARMACOLOGY
- Breast Cancer Bone Metastases: It’s All about the Neighborhood
- (2013) Theresa A. Guise CELL
- Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial
- (2013) Dino Amadori et al. LANCET ONCOLOGY
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
- (2010) Anders Bonde Jensen et al. Clinical Breast Cancer
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
- (2009) Lauren K. Dunn et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started